Medicine recalls
|
| |
| Canada: Recall: Teva-Indomethacin: Out of specification |
| |
Health Canada announces that Teva Canada Limited is recalling 3 lots of Teva-Indomethacin 50 mg Capsules (lot number: 100072497, 100072498, 100072499) because the assay may be out of specification in the affected lots.
The product is indicated for the symptomatic treatment of rheumatoid arthritis, ankylosing (rheumatoid) spondylitis, osteoarthritis, degenerative joint disease (osteoarthritis) of the hip, and gout.
Please refer to the following website in Health Canada for details:
http://recalls-rappels.canada.ca/en/alert-recall/teva-indomethacin-out-specification
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Friday, Feb 20, 2026
Issued at HKT 17:30
|
| |
